Other publications - David Woolfe

Original Publications


Assessing response to treatment of bone metastases from breast cancer: What should be the standard of care?
Annals of Oncology. 2015: 26(6) 1048-57.
Woolf DK, Padhani AR, Makris A


Screening criteria in breast cancer trials: are they too restrictive?
Clinical Oncology. 2015: 27, 542.
Woolf DK, Miles D, Nathan P, Windmill E, Makris A


MRI, Digital Mammography and Sonography: tumour characteristics and tumour biology in primary setting
J Natl Cancer Inst Monogr. 2015: 51, 15-20.
Woolf DK, Padhani AR, Makris A


Stereotactic body radiotherapy (SBRT) in the management of extra-cranial oligometastatic disease
B J Radiol. 2015 Mar 5: 20140712
Bhattacharya IS, Woolf DK, Hughes R, Shah N, Harrison M, Ostler PJ, Hoskin PJ


Arterial Input Functions in Dynamic Contrast Enhanced Magnetic Resonance Imaging: Which model performs best for assessing breast cancer response?
Accepted in BJR (May 15)
Woolf DK, Taylor NJ, Makris A, Tunariu N, Collins DJ, Li SP, Ah-See, M-L, Beresford M, Padhani AR


Outcomes of primary lymphoma of the ocular adnexa (orbital lymphoma) treated with radiotherapy
Clinical Oncology. 2015: 27, 153-159.
Woolf DK, Kuhan H, Shoffren O, Akinnawo EM, Sivagurunathan B, Boyce H, Plowman PN


Hypofractionated radiotherapy for localised prostate cancer using three dimensional conformal radiotherapy technique: 3 year toxicity analysis
In Journal of Cancer (2015)
White R, Woolf DK, Li SP, Alonzi R, Osler O, Hoskin P, Hughes R


Assessing response in breast cancer with dynamic contrast enhanced magnetic resonance imaging: Are signal intensity/time curves adequate?
Breast Cancer Research and Treatment. 2014: 147,335-343
Woolf DK, Padhani AR, Taylor N.J, Gogbashian A, Li S, Beresford M, Ah-See M-L, Stirling J, Collins D, Makris A


Biological dosimetry for breast cancer radiotherapy: A comparison of external beam and intraoperative radiotherapy
SpringerPlus. 2014: 3:329
Woolf DK, Williams NR, Bakhshi R, Madani Y, Eaton D, Fawcitt S, Pigott K, Short SC,
Keshtgar MR


Could clinical oncology training address manpower issues in low and middle income countries?
Clinical Oncology. 2014: 26, 730-731.
Woolf DK, Aggarwal A


Evaluation of FLT PET-CT as an imaging biomarker of proliferation in primary breast cancer
British Journal of Cancer. 2014: 110,2847-2854.
Woolf DK, Beresford M, Li S, Dowsett M, Sanghera B, Wong W, Sonoda L, Detre S, Amin V, Ah-See M-L, Miles D, Makris A


The Current Views of Clinical Oncology Trainees
Clinical Oncology. 2014: 26,159-161.
Said J, Woolf DK, Glendenning J, Leaning D, Manetta C


FLT PET-CT in evaluation of treatment response
In J Nucl Med. 2014; 29,65-73.
Sanghera B, Wong WL, Sonoda LI, Beynon G, Makris A, Woolf DK, Ardeshna K


Intraoperative radiotherapy for breast cancer deserves a mention
Clinical Oncology. 2014: 26,121-122
Woolf DK, Keshtgar M


Fractionated stereotactic radiotherapy for acoustic neuromas: Long term outcomes
Clinical Oncology. 2013: 25,734-738.
Woolf DK, Williams M, Goh C, Henderson D, Menashy R, Simpson N, Mastroianni B, Collis C


Routine clinical data predicts survival after palliative radiotherapy: An opportunity to improve end of life care
Clinical Oncology. 2013: 25,668-673.
Williams M, Woolf DK, Dickson J, Hughes R, Maher J


Primary Lymphoma of the Ocular Adnexa (Orbital Lymphoma) and Primary Intraocular Lymphoma
Clinical Oncology. 2012: 24,339-344
Woolf DK, Ahmed M, Plowman PN


Change in platelet levels during radiotherapy with concurrent and adjuvant temozolomide for treatment of glioblastoma: a novel prognostic factor for survival
Journal of Cancer Research and Clinical Oncology. 2012 Oct: 138(10),1683-8.
Williams M, Liu Z-W, Woolf D, Hargreaves S, Michalarea V, Menashy R, Kooner I, Wilson E


The evolution and current paradigm of chemotherapy for metastatic castrate-resistant prostate cancer
British Journal of Medical and Surgical Urology 2011:4S,S2-8
Payne H A, Aggarwal A, Woolf DK


The Use of Symptoms to predict Colorectal Cancer site. Can we reduce the pressure on our endoscopy services?
Colorectal Disease. 2010: 12,114-118.
Kent AJ, Woolf D, McCue J, Greenfield SM


Always Check the Labels
British Journal of Hospital Medicine. 2007;68:2:108
Woolf D, Trudgill N


Book Chapters


A case of thyroid cancer
Book chapter: Challenging Concepts in Oncology; Oxford University Press, April 2015
Woolf DK, Dallas N


Oral and Poster Presentations


Outcomes and toxicities in advanced anal cancer treated with VMAT chemoradiotherapy
Accepted for Poster Presentation: ESTRO 35 (April 16)
Jiad E, Woolf DK, Pasha N, Ball S, Raouf S


Is a watch and wait policy after chemo-radiotherapy for rectal cancer detrimental to outcome?
Accepted for Poster Presentation: ESTRO 35 (April 16)
Pasha N, Woolf DK, Jiad E, Ball S, Raouf S


Does dose-escalated neo-adjuvant radiotherapy improve pathological response in rectal cancers?
Accepted for Poster Presentation: ESTRO 35 (April 16)
Pasha N, Woolf DK, Martinou M, Williams K, Ball S, Raouf S


Routine Whole Body MRI of bone metastases may reduce the incidence of spinal cord compression
Accepted for Poster Presentation: ESTRO 35 (April 16)
Bhattacharya I, Woolf DK, Makepeace A, Kosmin M, Makris A, Hoskin P, Padhani A


Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone: A Whole Body MRI Study
Poster Presentation: UK Breast Cancer Meeting (Nov 15)
Kosmin M, Woolf DK, Padhani A, Makris A


Doctors’ views on audio recording of oncology consultations by patients
Poster Presentation: National Cancer Research Institute (Nov 15)
Ariyaratne H, Woolf DK


A review of bladder filling protocols for patients receiving radical pelvic radiotherapy
Poster Presentation: ESTRO Forum (April 15)
Wong S, Woolf DK, Beaton L, Shoffren O, Powell M


Radiation-induced brainstem necrosis: A case control study
Poster Presentation: EORTC-EANO-ESMO CNS meeting (Mar 15)
Woolf DK, Goh CL, Henderson DR, Menashy R, Simpson N, Mastroianni B, Collis CH, Williams MH


Stereotactic body radiotherapy (SBRT) in difficult-to-treat areas (para-aortic lymphadenopathy and pelvic recurrence) in oligometastatic colorectal carcinoma
Poster Presentation: Gastrointestinal Cancer Symposium (Jan 15)
Bhattacharya IS, Woolf DK, Hughes R, Harrison M


Clinical trials in oncology: are the results generalisable?
Poster Presentation: National Cancer Research Institute & UK Breast Cancer Meeting
Woolf DK, Miles D, Nathan P, Windmill E, Makris A (Nov 14)


FLT PET-CT and response prediction to neoadjuvant chemotherapy in primary breast cancer
Poster Presentation: National Cancer Research Institute (Nov 14)
Nominated for RCR Ross prize
Woolf DK, Beresford M, Li S, Sanghera B, Wong W, Amin V, Ah-See M-L, Miles D, Sonoda L, Detre S, Dowsett, M, Makris A


Outcomes of stereotactic body radiotherapy (SBRT) in oligometastatic disease
Accepted for Poster Presentation: National Cancer Research Institute (Nov 14)
Bhattacharya IS, Woolf DK, Hughes R, Shah N, Ostler P, Hoskin PJ, Harrison M


Biological dosimetry with γ-H2AX foci using radiotherapy for breast cancer as a model
Poster Presentation: American Society for Radiation Oncology (ASTRO) (Sept 14)
Woolf DK, Williams NR, Bakhshi R, Madani Y, Fawcitt S, Eaton D, Pigott K, Short S,
Keshtgar MR


Functional imaging techniques in the management of breast cancer: A multimodality approach
Oral Presentation: The Institute of Cancer Research Conference (June 14)
Awarded ICR oral presentation prize
Woolf DK


Assessing breast cancer response with DCE-MRI: Are signal intensity/time curves adequate?
Poster Presentation: ISMRM Annual Meeting. No. 4053 (May 14)
Woolf DK, Li SP, Taylor NJ, Makris A, Gogbashian A, Beresford MJ, Ah-See M-L, Stirling JJ, Collins DJ, Padhani AR


Assumed AIFs in DCE-MRI: Which performs best for assessing breast cancer response?
Poster Presentation: ISMRM Annual Meeting. No. 4068 (May 14)
Woolf DK, Taylor NJ, Tunariu N, Makris A, Li SP, Ah-See M-L, Beresford MJ, Stirling JJ, d’Arcy JA, Collins DJ, Padhani AR


Evaluation of FLT PET-CT as an imaging biomarker of proliferation in primary breast cancer
Poster Presentation: San Antonio Breast Cancer Symposium (Dec 13)
Cancer Research: 73, 2013: P4-01-07
Woolf DK, Beresford M, Li S, Sanghera B, Wong W, Amin V, Ah-See M-L, Miles D, Sonoda L, Detre S, Dowsett, M, Makris A

Assessing response in breast cancer with dynamic contrast enhanced magnetic resonance imaging: Are signal intensity time curves adequate?
Poster Presentation: San Antonio Breast Cancer Symposium (Dec 13)
Cancer Research 73, 2013: P4-01-08
Woolf DK, Padhani AR, Li S, Beresford M, Taylor N.J, Ah-See M-L, Stirling J, Gogbashian A, Makris A


An observational study using γ-H2AX foci to investigate cardiac doses of radiation in women following adjuvant radiotherapy for breast cancer: External beam radiotherapy versus targeted intraoperative radiotherapy
Poster Presentation: San Antonio Breast Cancer Symposium (Dec 13)
Cancer Research: 73, 2013: P5-14-13
Woolf DK, Williams NR, Bakhshi R, Madani Y, Fawcitt S, Pigott K, Short S, Keshtgar MR


Review: Can FLT PET-CT predict treatment response?
Poster Presentation: Annual Congress of the European Association of Nuclear Medicine (Oct 13)
Eur J Nucl Med Mol Imaging: Vol 40(2), 2013: S411
Sanghera B, Sonoda L, Woolf DK, Makris A, Wong W


FLT PET-CT Functional texture analysis has potential to distinguish breast cancer patients
Poster Presentation: Annual Congress of the European Association of Nuclear Medicine (Oct 13)
Eur J Nucl Med Mol Imaging: Vol 40(2), 2013: S305
Sanghera B, Sonoda L, Woolf DK, Makris A, Wong W


Recent experience of localised radiotherapy for low grade orbital lymphoma at a tertiary referral centre
Poster Presentation: European Cancer Congress (Sept 13)
Eur J Cancer: Vol 49(S2), 2013: S841
Kuhan H, Woolf DK, Shoffren O, Akinnawo E, Boyce H, Tai X, Perry E, Uddin J, Rose G, Plowman PN


FLT PET breast cancer exhibits 3D fractal characteristics pre and during therapy
Poster Presentation: British Nuclear Medicine Society Annual Meeting (Apr 13)
Nuclear Medicine Communications: Vol 34, 2013: 363-411
Sanghera B, Sonoda L, Woolf DK, Makris A, Wong W


FLT PET-CT breast cancer distinguished with 3D lacunarity analysis pre and post therapy
Poster Presentation: British Nuclear Medicine Society Annual Meeting (Apr 13)
Nuclear Medicine Communications: Vol 34, 2013: 363-411
Sanghera B, Sonoda L, Woolf DK, Makris A, Wong W


Three years experience of chemotherapy for small cell lung cancer at a tertiary referral centre
Poster Presentation: British Thoracic Oncology Group (Jan 13)
Lung Cancer: Vol 79, Jan 13: S65
Hough N, Lewis A, Woolf DK, Reeves A, Szlosarek P, Wells P, Steele J


Systemic therapy in the management of non-small cell lung cancer (NSCLC): the real world experience
Poster Presentation: British Thoracic Oncology Group (Jan 13)
Lung Cancer: Vol 79, Jan 13: S17
Lewis A, Hough N, Woolf DK, Reeves A, Szlosarek P, Wells P, Steele J


Rituximab alone in the management of primary orbital lymphoma of the conjunctiva
Poster Presentation: National Cancer Research Institute (Nov 12)
Nominated for RCR Ross prize
Woolf DK, Kuhan H, Qureshi A, Wong S-L, Cohen V, Plowman PN


The Mount Vernon Hospital experience of hypofractionated 57 Gy in 19 fractions radiotherapy for organ-confined prostate cancer: 3 year outcome data
Poster Presentation: British Uro-Oncology Group. (Sept 12)
Clinical Oncology. Vol 25, Issue 4, April 13: e70
Dubash S, Woolf DK, Verma R, Treasure P, Hughes R


Fractionated stereotactic radiotherapy for vestibular schwannoma (VS): A review of long term outcomes
Oral Presentation: International Congress of the World Federation of Skull Base
Societies (May 12)
Journal of Neurosurgery 2012: 73 B2 161
Woolf DK, Williams MH, Henderson DR, Goh CL, Menashy R, Simpson N, Mastroianni B, Quiney, Thorne L, Bradford R, Saeed SR, Collis CH


Acoustic neuromas: evaluation of outcomes and toxicity with the use of fractionated stereotactic radiotherapy
Poster Presentation: European Society for Therapeutic Radiation and Oncology
Radiotherapy & Oncology 2012: 103 S257 (May 12)
Woolf DK, Williams MH, Henderson DR, Goh CL, Menashy R, Simpson N, Mastroianni B, Collis C


Radiotherapy in squamous cell carcinoma of the penis: A review of the data from a tertiary referral centre (Nov 11)
Poster Presentation: European Multidisciplinary Meeting on Urological Cancers
Kosmin M, Woolf DK, Aggarwal A, Abdul N, Minhas S, Munner A, Payne H, Mitra A


An observational study using γ-H2AX foci to investigate cardiac doses of radiation following adjuvant radiotherapy for breast cancer: Standard external beam radiotherapy to the breast versus intraoperative radiotherapy
Poster Presentation: American Society of Clinical Oncology (May 11)
J Clin Oncol 2011: 29 TPS129
Woolf DK, Bakhshi R, Fawcitt S, Worku M, Ghosh DB, Sivabalasingham S, Williams NR, Short S, Pigott K, Keshtgar MR


Pre-treatment platelet count as a prognostic marker in patients with Glioblastoma (GBM) treated with radiotherapy and concurrent and adjuvant temozolomide (RCAT)
Poster Presentation: European Society for Medical Oncology (Dec 10)
Annals of Oncology 2010 21:S8 331
Williams M, Michalarea V, Hargreaves S, Woolf DK, Liu Z-W, Wilson E


Survival in patients receiving radiotherapy plus concomittent and adjuvant temozolomide (RCAT) for glioblastoma (GBM)
Poster Presentation: American Society for Radiation Oncology (Dec 10)
Int Joun Rad Biol Phys: 2010 78; 3 S281-282
Hargreaves S, Williams M, Liu Z-W, Michalarea V, Woolf DK, Wilson E


Audit of radiotherapy practice for metastatic spinal cord compression at a UK tertiary referral centre
Poster Presentation: National Cancer Research Institute (Nov 10)
Woolf DK, Aggarwal A, Chauhan B, Hughes R


Survival after first course of palliative radiotherapy: An observational cohort study
Oral and Poster presentation: National Cancer Research Institute (Nov 10)
Highly commended BOA young investigator award
Williams M, Woolf DK, Hughes R, Maher J, Dickson J.


Hypofractionated external beam radiotherapy to the prostate: Analysis of late toxicity
Poster Presentation: European Society for Therapeutic Radiation and Oncology
Radiotherapy & Oncology 2010 95;1 S404 (Sept 10)
Woolf DK, Li S P, Verma R, Treasure P, Hughes R


Audit of local outcomes of Glioblastoma Multiforme treated with radiotherapy and
concomitant and adjuvant temozolomide (RCAT)
Poster Presentation: Royal College of Radiologists Audit Forum (May 10)
Hargreaves S, Williams M, Woolf DK, Lui Z-W, Michelarou V, Wilson E


Prospective Study of Radiotherapy Toxicity Associated with the use of Hypofractionated 57Gy in 19 Fraction External Bream Radiotherapy to the Prostate
Poster Presentation: European Multidisciplinary Meeting on Urological Cancer
Woolf DK, Li SP, Verma R, Treasure P, Hughes R (Nov 09)


Colorectal cancer and the predictive ability of symptoms: can we stop colonoscoping patients?
Poster Presentation: United European Gastroenterology Week (Oct 08)
Gut/Endoscopy 2008;57(Suppl 1):A362
Kent AJ, Woolf DK, McCue J, McIntyre P, Morris D, Greenfield SM


Prospective Audit of Acute Radiotherapy Toxicity Associated with the use of Hypofractionated 57Gy in 19 Fraction External Beam Radiotherapy to the Prostate
Poster Presentation: British Uro-Oncology Group. (Sept 08)
Clinical Oncology. Vol 21, Issue 1, Feb 09: 71
Woolf DK, Li S P, Verma R, Treasure P, Hughes R


Rigid, Flexible, or the whole colon?
Poster Presentation: British Society of Gastroenterology Annual Meeting and the Association of Coloproctology of Great Britain and Ireland Annual Meeting (July 08)
Colorectal Disease. 10 (suppl 1) 2008: 16
Woolf DK, Kent AJ, Sibthorpe L, McCue J, Greenfield SM

;